Developing an innovative office‐based UK rhinology service—Experience and outcomes in 22 patients undergoing office‐based local anaesthetic nasal polypectomy

Coates, Matthew L; Mayer, A W; Carrie, Sean

doi:10.1111/coa.13487

Cited by 3 publications

(5 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For CRSwNP, microdebrider‐assisted polypectomy can be utilized in patients with recurrent polyposis after ESS 1804,1805 . Steroid‐eluting stent placement in the ethmoid cavity is another effective in‐office treatment option for recurrent polyposis after ESS 1606,1608,1806 .…”

Section: Surgery For Chronic Rhinosinusitismentioning

confidence: 99%

International consensus statement on allergy and rhinology: rhinosinusitis 2021

Orlandi

Kingdom

Smith

et al. 2021

Int Forum Allergy Rhinol

458

479

View full text Add to dashboard Cite

I. Executive Summary Background The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed foundational progress in our understanding and treatment of rhinologic disease. These advances are reflected within the more than 40 new topics covered within the ICAR‐RS‐2021 as well as updates to the original 140 topics. This executive summary consolidates the evidence‐based findings of the document. Methods ICAR‐RS presents over 180 topics in the forms of evidence‐based reviews with recommendations (EBRRs), evidence‐based reviews, and literature reviews. The highest grade structured recommendations of the EBRR sections are summarized in this executive summary. Results ICAR‐RS‐2021 covers 22 topics regarding the medical management of RS, which are grade A/B and are presented in the executive summary. Additionally, 4 topics regarding the surgical management of RS are grade A/B and are presented in the executive summary. Finally, a comprehensive evidence‐based management algorithm is provided. Conclusion This ICAR‐RS‐2021 executive summary provides a compilation of the evidence‐based recommendations for medical and surgical treatment of the most common forms of RS.

show abstract

Section: Surgery For Chronic Rhinosinusitismentioning

confidence: 99%

International consensus statement on allergy and rhinology: rhinosinusitis 2021

Orlandi

Kingdom

Smith

et al. 2021

Int Forum Allergy Rhinol

458

479

View full text Add to dashboard Cite

show abstract

“…Office-based rhinology is gaining traction among American Rhinologic Society (ARS) members, with increased adoption across various practice settings [1]. This trend, however, is not fully understood in other parts of the world [5,6].…”

Section: Discussionmentioning

confidence: 99%

“…Recent research explores the use of office-based rhinology for managing chronic rhinosinusitis with nasal polyposis, simple polypectomy [5], steroid-eluting stents [10], and inferior turbinate reduction [11]. Despite small patient numbers, these studies report favorable outcomes for IORPs.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Evaluating the Quality and Safety of In-Office Rhinologic Procedures: A YO-IFOS Pilot Study

Lobo,

Calvo,

Maza-Solano

et al. 2024

Surgeries

View full text Add to dashboard Cite

The primary objective of this pilot study was to identify which aspects of in-office rhinologic procedures (IORPs) warrant further attention and investigation in the future. The secondary objectives were to survey which IORPs are most common and to identify needs for education and training. A cross-sectional study was carried out following the Consensus-Based Checklist for Reporting of Survey Studies (CROSS). The survey collected demographic, organizational, quality, and safety aspects of IORPs and was electronically distributed to YO-IFOS members across five continents. A total of 194 surgeons completed the survey, and 172 respondents (88%) performed IORPs. Ninety-nine responders (51.5%) worked in an academic setting. Common procedures included powered polypectomy (48, 28.4%) and turbinate reduction (93, 54.1%). The main concerns were about patients’ tolerance (116, 76.3%) and about the safety of the procedure (102, 67.1%). The most important barriers to the diffusion of IORPs are concerns about the tolerance and safety of these procedures. It would be convenient to establish protocols for this type of procedure to ensure the greatest patient comfort based on evidence.

show abstract

“…This technique seems to be cost effective [8] and has relatively long-standing beneficial results in the quality of life of patients [9]. However, the impact and expansion of this therapy in Europe has been very low in comparison to North America.…”

Section: Introductionmentioning

confidence: 99%

In-office endoscopic nasal polypectomy: prospective analysis of patient tolerability and efficacy

Viera‐Artiles

Corriols-Noval

López-Simón

et al. 2020

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

Purpose In-office rhinologic procedures have become popularised in the last decade, especially in North America. Endoscopic nasal polypectomy under local anaesthesia offers instant relief in selected patients with obstructive chronic rhinosinusitis with nasal polyps. We aimed to analyse patient tolerability during the procedure while measuring its effectiveness. Methods A prospective study of patients who underwent in-office microdebrider-assisted polypectomy under local anaesthetic from September 2018 to November 2019 in a Spanish tertiary hospital was performed. The tolerability was measured by monitoring vital signs during the procedure and using a visual analogue scale posteriorly. The effectiveness was calculated through patient-reported outcomes (SNOT-22) and endoscopic evaluation 1 and 6 months follow-up. Results Forty-four patients were included, with a mean age of 60.7 years. The mean visual analogue scale score was 2.76 out of 10 points. Vital signs were steady overall, with a statistically significant reduction (p < 0.001) in systolic pressure during the procedure. Presyncope and epistaxis were among the few mild complications. However, we registered one major complication that required intensive care admission. There was a 64% reduction in the SNOT-22 score in the first month, with a maintained effect after 6 months. Patients with asthma and a higher polyp load were the subgroups that required more time to achieve significant improvement. Conclusions In-office polypectomy is a very effective technique that alleviates obstructive symptoms in patients with nasal polyposis, and it is generally safe and well tolerated when performed by an expert. However, rhinologists must be aware of potentially severe complications.

show abstract

Developing an innovative office‐based UK rhinology service—Experience and outcomes in 22 patients undergoing office‐based local anaesthetic nasal polypectomy

Cited by 3 publications

References 9 publications

International consensus statement on allergy and rhinology: rhinosinusitis 2021

International consensus statement on allergy and rhinology: rhinosinusitis 2021

Evaluating the Quality and Safety of In-Office Rhinologic Procedures: A YO-IFOS Pilot Study

In-office endoscopic nasal polypectomy: prospective analysis of patient tolerability and efficacy

Contact Info

Product

Resources

About